These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20668822)

  • 21. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Climacteric symptoms: intensity, incidence and need for treatment. A study of 716 women between 40 and 70 years of age].
    Wenderlein JM; Clauder C
    Zentralbl Gynakol; 1996; 118(11):598-604. PubMed ID: 9082692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current considerations of the menopause.
    Wu CH
    Ann Clin Lab Sci; 1985; 15(3):219-28. PubMed ID: 3994291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
    Benshushan A; Rojansky N; Chaviv M; Arbel-Alon S; Benmeir A; Imbar T; Brzezinski A
    Climacteric; 2009 Oct; 12(5):404-9. PubMed ID: 19479488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Low-dose hormonal therapy during climacteric].
    Carranza Lira S
    Ginecol Obstet Mex; 2008 May; 76(5):267-74. PubMed ID: 18798431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.
    Skouby SO; Barlow D; Samsioe G; Gompel A; Pines A; Al-Azzawi F; Graziottin A; Hudita D; Rozenberg S;
    Maturitas; 2004 May; 48(1):19-25. PubMed ID: 15223104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychosocial aspects of the climacteric].
    Buddeberg C; Buddeberg-Fischer B
    Praxis (Bern 1994); 1995 Jun; 84(24):718-21. PubMed ID: 7792468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Climacteric symptoms and hormones.
    Schindler AE
    Gynecol Endocrinol; 2006 Mar; 22(3):151-4. PubMed ID: 16835077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two routes of hormonal replacement therapy in symptomatic menopausal women after kidney transplantation.
    Pietrzak B; Wielgos M; Kaminski P; Bobrowska K
    Neuro Endocrinol Lett; 2006 Jun; 27(3):387-91. PubMed ID: 16816826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New forms of estrogenotherapy in postmenopausal osteoporosis].
    Meczekalski B; Czyzyk A
    Pol Merkur Lekarski; 2009 Jul; 27(157):77-80. PubMed ID: 19650437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menopause and estrogen replacement therapy.
    Stuenkel CA
    Psychiatr Clin North Am; 1989 Mar; 12(1):133-52. PubMed ID: 2652104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Climacteric--medicalization, minimalization or normalization?].
    Hovelius B; Ekström H; Esseveld J; Landgren BM; Vinge E
    Lakartidningen; 2000 Dec; 97(50):5927-30. PubMed ID: 11188537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S; Moghasemi M; Faghihzadeh S
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.
    Ren J; Kelley RO
    Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
    van de Weijer PH; Mattsson LA; Ylikorkala O
    Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Menopausal transition, physiopathology, clinical and treatment].
    Blumel JE; Cruz MN; Aparicio NJ
    Medicina (B Aires); 2002; 62(1):57-65. PubMed ID: 11965854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.